Related Experiment Video
Updated: Aug 8, 2026

Isolation and Functional Characterization of Human Ventricular Cardiomyocytes from Fresh Surgical Samples
Published on: April 21, 2014
Outcome of idiopathic restrictive cardiomyopathy in children
Rachel J Weller1, Robert Weintraub, Linda J Addonizio
1Division of Pediatric Cardiology, Department of Pediatrics, College of Physicians and Surgeons, Columbia University, New York, New York, USA.
Insights
Idiopathic restrictive cardiomyopathy (IRC) in children often leads to pulmonary hypertension, a predictor of poor outcomes. Early monitoring of pulmonary vascular resistance index (PVRI) is crucial for timely cardiac transplant evaluation.
Area of Science:
- Pediatric Cardiology
- Cardiovascular Research
- Pulmonology
Background:
- Idiopathic restrictive cardiomyopathy (IRC) is a rare condition in children.
- Identifying predictors of poor outcomes in pediatric IRC is essential for management.
Purpose of the Study:
- To identify potential predictors of poor outcomes in children with idiopathic restrictive cardiomyopathy (IRC).
- To investigate the role of pulmonary hypertension in the prognosis of pediatric IRC.
Main Methods:
- Retrospective study of 18 children diagnosed with idiopathic restrictive cardiomyopathy (IRC).
- Analysis of clinical presentation, cardiac output (CO) syndrome development, hemodynamic parameters including pulmonary vascular resistance index (PVRI), and outcomes.
- Comparison of PVRI in IRC patients with those of children with dilated cardiomyopathy referred for heart transplant.
Main Results:
- Four patients presented with low cardiac output (CO) syndrome; 14 developed it later.
- Elevated pulmonary vascular resistance index (PVRI >6 U-m(2)) was observed in 10 of 18 patients and was associated with death (p <0.01).
- Severe pulmonary hypertension precluded 40% of eligible patients from cardiac transplantation.
Conclusions:
- Elevated PVRI is a significant predictor of poor outcomes and mortality in pediatric idiopathic restrictive cardiomyopathy (IRC).
- Pulmonary hypertension can be a contraindication for cardiac transplantation in children with IRC.
- Serial monitoring of PVRI in children with IRC is recommended to guide timely transplant evaluation.
Abstract:
Eighteen children with idiopathic restrictive cardiomyopathy (IRC) were studied in an attempt to identify potential predictors of poor outcome. Four patients presented with low cardiac output (CO) syndrome. Fourteen remaining patients were minimally symptomatic at presentation but developed a low CO syndrome at a mean of 2.8 +/- 2.3 years after diagnosis. At the time of development of low CO in the 18 patients, mean left ventricular end-diastolic pressure was 27 mm Hg, right ventricular end-diastolic pressure was 18 mm Hg, cardiac index was 2.5 L/min/m(2), and pulmonary vascular resistance index (PVRI) was 8.8 U-m(2). Eleven of the 18 patients underwent cardiac transplantation. One died perioperatively from donor right-sided cardiac failure and 10 survived. Six were not transplanted and died, including 3 in whom transplantation was precluded secondary to extremely elevated PVRI. One patient is alive with right-sided cardiac failure. Ten of our 18 patients had pulmonary hypertension (PVRI >6 U-m(2)) at the time of referral for cardiac transplant and/or development of low CO syndrome. In comparison, children with dilated cardiomyopathy who were referred for heart transplant during the same time period had a PVRI that was significantly lower (5.2 U-m(2)). Elevated PVRI was associated with death (p <0.01) and 40% of our children with pulmonary hypertension were precluded from receiving an orthotopic heart transplant because their pulmonary hypertension was so severe. No risk factors for the development of pulmonary hypertension were identified; therefore, all children with IRC should undergo serial monitoring of their PVRI, and any increase should prompt a transplant evaluation.
More Related Videos
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy V: Interprofessional Care

